High-throughput Screening Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product Service, by Technology, by Application and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

High throughput screening is a technique employed to discover and design drugs. The technique involves numerous steps such as target identification, reagent preparation, compound management, assay development, and high-throughput library screening such as large number of biological effectors and modulators are screening against the specific target. Moreover, high-throughput screening technique is useful to reduce the cost of drug development. In addition, this technique helps to screen large number of compounds by HTS up to at least 10,000 compounds per day and by using ultrahigh-throughput screening (UHTS) it can conduct even 100,000 assays per. The technique utilizes robots, detectors, and software, which control the entire process. Furthermore, it is used for screening different types of libraries such as combinatorial chemistry, peptide, genomics, and proteins libraries. It is further used to characterize metabolic, pharmacokinetic, and toxicological data about new drugs.

The global high throughput screening market is expected to witness significant growth during the forecast period due to factors such as rise in use of high-throughput screening for drug development, as it reduces the time taken to develop a drug. In addition, development of new drugs for various life-threating diseases contributes toward the growth of the market. Moreover, increase in funding from government for adoption of new technologies such as microplate-free approach, CRISPR-Cas9 & RNAi, and artificial intelligence & machine learning fuels the growth of the market. Furthermore, faster data processing and rise in automation in the field of high throughput screening boost the growth of market. However, high capital investments and lack of skilled professionals in developing countries & underdeveloped countries are certain factors that hamper the growth of the high-throughput screening market. Based on technology, the label-free technology is expected to grow at higher rate during the forecast period, as it provides simple methods for studying complex biological pathways and reduces the risk of drug failure caused by toxicity which help in the growth of the high throughput screening market.

The global high-throughput screening market is divided based on technology, product & service, application, end user, and region. On the basis of product and service, the High-throughput Screening Market is classified into reagents & assay kits, instruments, consumables & accessories, software, and services. By technology, it is categorized into cell-based assays, 2D cell culture, 3D cell culture, perfusion cell culture, lab-on-a-chip (LOC), ultrahigh-throughput screening, bioinformatics, and label-free technology. The segment 3D cell culture is further divided into scaffold-based technologies and scaffold-free technologies. The scaffold-based technologies segment is further fragmented into hydrogels, inert matrix, micropatterned surfaces and scaffold-free technologies are divided into microplate hanging-drop plates, and ultralow binding plates. The applications covered in the study include target identification & validation, primary & secondary screening, and toxicology assessment. Depending on end user, the market is segregated into pharmaceutical & biotechnology companies, academic & government institutes, and contract research organizations. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain the UK, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

High-throughput screening market is highly competitive market, with the presence of numerous major players such as Thermo Fisher Scientific, Agilent Technologies, Inc., Danaher , PerkinElmer, Inc, Tecan Group Ltd., Axxam S.p.A, Bio-Rad Laboratories Inc, Merck Group KGaA, Hamilton Company, Corning Incorporated, Biotek Instruments Inc., and Aurora Biomed Inc.

KEY BENEFITS FOR STAKEHOLDERS

• This report provides a detailed quantitative analysis of the current trends and future estimations, which assist to identify the prevailing market opportunities. 
• An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
• A comprehensive analysis of the factors that drive and restrain the growth of the global high throughput screening market is provided.
• Region-wise and country-wise market conditions are comprehensively analyzed in this report.
• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

  High-throughput Screening Market Report Highlights

Aspects	Details
By Product & Service	Reagents & Assay Kits Instruments Consumables & Accessories Software Services
By Technology	Cell-based Assays 2D Cell Culture Perfusion Cell Culture Lab-on-a-chip (LOC) Ultrahigh-throughput Screening Bioinformatics Label-free Technology 3D Cell Culture Scaffold-based Technologies Hydrogels Inert Matrix Micropatterned Surfaces Scaffold-free Technologies Microplate Hanging-drop Plates Ultralow Binding Plates Other Scaffold-free Technologies
By Application	Target Identification & Validation Primary and Secondary Screening Toxicology Assessment Others
By End User	Pharmaceutical & Biotechnology Companies Academic & Government Institutes  Contract Research Organizations Others
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	PerkinElmer, Inc., Bio-Rad Laboratories Inc., Hamilton Company, Danaher, Merck Group KGaA, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Tecan Group Ltd., Axxam S.p.A, Corning Incorporated, Biotek Instruments Inc., Aurora Biomed Inc.